Drugs / TERN-601
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2 | NCT06854952 | Mar → Aug 2025 | obesity disorder | Terns, Inc. | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | TERN-601 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT06854952 ↗ |
| Route | Oral | “orally administered TERN-601” NCT06854952 ↗ |